Flextronics acquires Stellar Microelectronics

NewsGuard 100/100 Score

Flextronics (NASDAQ: FLEX) today announced that it has completed its previously announced acquisition of Stellar Microelectronics. The acquisition extends Flextronics' service offering in advanced custom packaging solutions that utilize the latest microelectronics technologies for the aerospace, defense and medical manufacturing markets and the ability to support customers with unique U.S. manufacturing needs such as AS9100C, ISO 9001:2008 and ISO13485:2003. The completion of this acquisition also increases Flextronics' aerospace, defense and medical customer portfolio.  

"We are very pleased to welcome the Stellar Microelectronics team to our organization. Through their hard work and dedication, they have built a highly successful organization with leading solutions across a diverse range of engineering, product development and production services," said Paul Humphries, group president of Flextronics High Reliability Solutions. "Our organization is now even better able to address the precision-dependent, high-demand needs of the aerospace, defense and medical manufacturing markets, and we look forward to delivering these services with our new team members from Stellar Microelectronics."

SOURCE Flextronics

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles